| 000 | 01417nam a2200337 a 4500 | ||
|---|---|---|---|
| 005 | 20250930113334.0 | ||
| 008 | 011127s2001 fr 000 0 eng d | ||
| 020 |
_a9264183043 _cRM72.67 |
||
| 039 | 9 |
_a201710231613 _bmadihah _c201612291353 _dmuhaimin _c201503231608 _dasrul _c200607270920 _dnorjismi _y11-27-2001 _zrosnah |
|
| 040 |
_aUKM _erda |
||
| 090 |
_aOECD 5 _bG463 |
||
| 245 | 0 | 0 |
_aGenetic testing : _bpolicy issues for the new millennium |
| 260 |
_aParis : _bOECD, _c2001 |
||
| 300 |
_a75 p. ; _c23 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aScience and innovation | |
| 490 | 1 | _aOECD proceedings | |
| 500 | _aTopics, issues and policy considerations discussed at the OECD Workshop on'Genetic testing: Policy Issues for the New Millennium' held in Vienna on 23-25 February 2000 co-sponsored by the European Commission, the Government of Austria and the United Kingdom | ||
| 504 | _aIncludes bibliographical references | ||
| 650 | 0 |
_aHuman chromosome abnormalities _xDiagnosis _vCongresses |
|
| 710 | 2 |
_aOrganisation for Economic Co-operation and Development _943115 |
|
| 830 | 0 | _aScience and innovation | |
| 907 |
_a.b12945365 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c4 _n0 _kOECD 5 G463 |
||
| 914 | _avtls000306188 | ||
| 991 | _aKoleksi Dokumen | ||
| 998 |
_at _b2001-01-11 _cm _da _feng _gfr _y0 _z.b12945365 |
||
| 999 |
_c294988 _d294988 |
||